Saina Nehwal, H S Prannoy test positive for COVID-19 again

The duo, along with the Indian team, was looking to participate in the Asia leg events comprising the Thailand Open (January 12-17), TOYOTA Thailand Open (January 19-24) and the HSBC BWF World Tour Finals 2020 (January 27-31).

PTI

January 12, 2021 / 11:39 IST

Saina Nehwal | Image: PTI

Top Indian shuttlers Saina Nehwal and H S Prannoy, who had recently recovered from COVID-19, have again tested positive for the dreaded disease here ahead of the Thailand Open which began on Tuesday.

The duo, along with the Indian team, was looking to participate in the Asia leg events comprising the Thailand Open (January 12-17), TOYOTA Thailand Open (January 19-24) and the HSBC BWF World Tour Finals 2020 (January 27-31).

"Saina and Prannoy tested positive for COVID-19 during a test conducted on Monday. They will stay in quarantine for 10 days in a Bangkok hospital. Kashyap too will have to head to the hospital as he is a close contact," a source in the Badminton Association of India (BAI) said.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

While the trio will miss the tournament, the rest of the Indian team players have been allowed to participate in the event.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show